The pre-exposure of monocytes to HPC-4 TLG , but not to HPC-4, cells did not decrease TNF nor increase IL-10 production, thus not leading to monocyte deactivation. Also, the antitumor cytotoxicity of monocytes stimulated with HPC-4 TLG was not downregulated, which occurred when non-transduced HPC-4 cells were used. In conclusion, compared to parental HPC-4 cells, TLG gene transduced HPC-4 cells induced stronger antitumor response of monocytes in vitro and prevented deactivation of mono-
A serious problem with the retroviral system of gene transfer is that it is difficult to maintain a high level of cloned gene expression following transduction. Usually, several passages of transduced cells result in the outgrowth of clones that express much lower levels of the transgene coded protein. The use of the internal ribosome entry site (IRES) elements rather than internal promoters could increase the likelihood of stable expression of the cloned gene of interest. However, even the use of IRES sequence does not completely reduce the number of potential mechanisms, both at the transcriptional and post-transcriptional levels, that could affect the transgene expression [1] . Cloned gene expression also depends on retroviral DNA integration site in the host genome [2, 3] . Cloning of the gene coding for green fluorescent protein (GFP) isolated from the jellyfish Aequorea victoria and its efficient species-independent expression is a new versatile reporter gene system [4, 5] .
Autologous cancer cells used as vaccines to enhance antitumor activity have been explored extensively, but their efficiency has proved to be low. There- www.fhc.viamedica.pl fore, genetically engineered tumor cells transfected with various cytokines coding genes have been used [6] [7] [8] . However, despite positive effects in murine experimental tumor models, their clinical efficiency in human cancer is marginal, with an objective response rate of 3.3% [9] . Also, human monocytes that exert a direct cytotoxic effect on tumor cells, as mediated by radical oxygen intermediates (ROI) and tumor necrosis factor (TNF), upon arrival at the tumor site form tumor infiltrating macrophages (TIM), which become polarized to M2 macrophages, thus strongly reducing their cytotoxic activity [10] . This occurs due to the tumor cell products, including extracellular matrix components, IL-10, CSF-1 and other cytokines. In general, M2 macrophages have poor antigen presenting capacity, have an IL-12 low and IL-10 high phenotype, suppress the inflammatory response and Th1 adaptive immunity, and promote angiogenesis, tissue remodeling and tumor progression [10] . Such TIM changes may be responsible, at least in part, for the inefficiency of tumor vaccines.
We have previously observed that human monocytes stimulated with tumor cells produce TNF, IL-10 and IL-12 [11] . However, when monocytes were first pre-exposed to tumor cells, sorted out from coculture and then re-stimulated with tumor cells, they became M2 polarized cells that produced increased amounts of immunosuppressive IL-10 [11] . Therefore, we wanted to investigate whether the use of TNF gene transduced tumor cells might increase their immunostimulatory potential for monocytes and prevent their M2 polarization. Material and methods  Material and methods  Material and methods  Material and methods   R  R R  R Reagents and antibodies eagents and antibodies eagents and antibodies eagents and antibodies eagents and antibodies. The oligonucleotides were purchased from TIB Molbiol (Poznan, Poland). Polymerase chain reaction (PCR) and enhanced avian reverse transcriptase (RT) kits, agarose (for routine use), polybrene (hexadimethrine bromide), and the antibiotics ampicillin, neomycin sulfate and tylosin tartrate were from Sigma Chemical Company (St. Louis, MO, USA). The Pwo DNA polymerase with the appropriate incubation buffer was obtained from Roche (Basel, Switzerland). Restriction enzymes, 1 Kb Plus DNA ladder and T4 DNA ligase were from Invitrogen (Carlsbad, CA, USA). The jetPEI cationic polymer transfection reagent was obtained from Qbiogene (Morgan, Irvine, CA, USA). DMEM and RPMI 1640 media (both with L-glutamine), and fetal bovine serum (FBS) were obtained from PAA Laboratories GmbH (Pashing, Germany). The RetroPack PT67 retrovirus packaging cell line was purchased from BD Biosciences Clontech (Mountain View, CA, USA). The following antibodies were used: phycoerythrin (PE)-conjugated monoclonal antibody (mAb) against human TNF and an appropriate isotype control (BD Pharmingen, San Diego, CA, USA), Alexa Fluor 594-conjugated rabbit polyclonal anti-GFP IgG antibody and rabbit anti-FITC Alexa Fluor 594-conjugated polyclonal IgG antibody (used as an isotype control), purified mouse anti--GFP IgG 1 mAb (all Molecular Probes, Willow Creek, Eugene, OR, USA), horseradish peroxidase-conjugated goat anti-mouse IgG (Santa Cruz Biotech, Santa Cruz, CA, USA), and anti-CD14 PE-labeled mAb (BD Pharmingen). Reagents for cell fixation and permeabilization (Cytofix/ /Cytoperm and Perm/Wash) were from BD Pharmingen. The retroviral plasmid vector pMIGR1 [12] was kindly provided by Dr. Warren S. Pear (University of Pennsylvania, Philadelphia, PA, USA).
Material and methods

Cell cultures Cell cultures Cell cultures
Cell cultures Cell cultures. The RetroPack PT67 murine dualtropic cell line was used for retrovirus packaging and production of retroviral pMIGR1 and recombinant pMIGR1-TLG (pTLG) vectors. The established human pancreatic adenocarcinoma (HPC-4) cell line [13] was used for transduction of the TLG fused gene by the recombinant retroviral infection. The PT67 cells and HPC-4 cells were grown in DMEM and RPMI 1640 media, respectively, supplemented with the following antibiotics: 50 μg/ml neomycin, 100 μg/ml ampicillin, 10 μg/ml tylosin, and 10% FBS referred to further as complete. Both cell lines were incubated at 37°C in a humidified 5% CO 2 atmosphere. All cell cultures were routinely tested for Mycoplasma sp. contamination using a Mycoplasma PCR ELISA kit (Roche Diagnostics GmbH, Penzberg, Germany).
Construction of fusion TLG transgene and retroviral Construction of fusion TLG transgene and retroviral Construction of fusion TLG transgene and retroviral Construction of fusion TLG transgene and retroviral Construction of fusion TLG transgene and retroviral vector preparation. vector preparation. vector preparation. vector preparation. vector preparation. The cDNA encoding human TNF (26 kDa) was obtained by the RT-PCR method using specific oligonucleotide primers and the total RNA sample isolated from human blood monocytes stimulated in vitro for 2 h with LPS (1 μg/ml). The synthesis of the first strand cDNA was carried out with enhanced avian RT and anchored oligo-dT primers according to the manufacturer's instructions. The PCR amplification of the first strand of TNF-cDNA was performed using the Pwo DNA polymerase and the following primers: BglFtnf sense 5'-GCGCA A A A AG G G G GA A A A ATCT TCT TCT TCT TCTATGAG-CACTGAAAGCATGAT-3' which provided BglII site (bolded) and XhoRtnf antisense 5'-CATATATCTCG CTCG CTCG CTCG CTCGA A A A AG -G -G -G -G -CAGGGCAATGATCCCAA-3' which provided XhoI site (bolded). The TNF-cDNA was cleaved with BglII and XhoI restriction enzymes and ligated to the BglII-XhoI linearized vector pMIGR1 to give the recombinant pMIGR1-TNF plasmid. The LIN23-cDNA sequence coding for a linker of 23 amino acid residues was synthesized in a PCR reaction using 82-mer oligonucleotide 5'-ATATACTCGAG-[(GGC) 4 P P P P Production of retroviral particles roduction of retroviral particles roduction of retroviral particles roduction of retroviral particles roduction of retroviral particles. The pTLG plasmid transfer was performed using the jetPEI transfection reagent according to the manufacturer's protocol. Transfected PT67 cells expressing the TLG protein were isolated by sorting with the use of FACS Vantage with DiVa option (BD Biosciences Immunocytometry Systems, San Jose, CA, USA) equipped with an aerosol protection system (Flexoduct International, Greve, Denmark) using DiVa software. The ion laser Innova Enterprise II (Coherent, Santa Clara, CA, USA) operating at 488 nm was used as a light source. Sorted PT67 cells were propagated in complete DMEM medium until cell culture reached confluency and sorted again. Double-sorted PT67 cells producing retrovirus were plated at 60-80% confluency in the desired number of culture vessels. The supernatants were harvested at 24 h intervals until cells were no longer viable. The supernatants were collected, spun at 500 × g for 10 min and stored at -70°C until use. Intracellular staining for the detection of GFP and TLG fusion protein was performed after cell fixation and permeabilization, as previously described [14] . Briefly, HPC-4 cells and their genetically modified clones were fixed and permeabilized with Cytofix/Cytoperm solution (BD Pharmingen) for 20 min at 4°C. Then, the cells were washed twice in Perm/Wash solution (BD Pharmingen) and pelleted cells were stained (30 min at 4°C) for intracellular detection of GFP and TLG fusion protein using Alexa Fluor 594-conjugated anti-GFP rabbit IgG and PE-conjugated mAb against human TNF. Appropriate matched isotype controls were used in parallel.
Flow cytometry analysis. Flow cytometry analysis. Flow cytometry analysis. Flow cytometry analysis. Flow cytometry analysis. Samples were analyzed in a FACS Canto flow cytometer (BD Biosciences) using DiVa software. The list mode data of 50,000 events from HPC-4 cells in a 'live gate' mode was acquired. The cells were gated according to FSC and SSC parameters. Intracellular GFP and TLG proteins were determined by green fluorescence measurement in channel FL1. Intracellular and membrane-bound TLG fusion proteins were also detected according to FL4 (Alexa Fluor 594-conjugated anti-GFP rabbit IgG) and FL2 (PE-conjugated mAb against human TNF) emission.
Isolation of cell populations Isolation of cell populations Isolation of cell populations Isolation of cell populations Isolation of cell populations. Human monocytes were separated from peripheral blood mononuclear cells of healthy donors by counter-flow elutriation, using a JE-6B elutriation system (Beckman Instruments, Palo Alto, CA, USA), as previously described [15] . They were 90-98% pure, as judged by staining with anti-CD14 mAb. Monocytes were suspended in RPMI 1640 medium with 5% FBS at the concentration of 1 × 10 6 cells/ml for in vitro cultures. In some experiments, monocytes isolated from a co-culture with parental or transduced HPC-4 cells (pre-exposure) at the ratio 1:0.3 for 4 h, were used. For this purpose, after staining with PE-labeled anti-CD14 (BD Biosciences) mAb, CD14 + cells were isolated by FACS sorting (FACS Vantage with DiVa option, Becton Dickinson Immunocytometry Systems). The purity of the sorted cells was checked by flow cytometry, and exceeded 95%. As control, CD14 + cells were sorted out from monocytes cultured in medium alone ('dummy sorting'). + cells were cultured in the medium alone or with parental HPC-4 or their genetically modified clones (as above), and the level of cytokines was measured. All the cytokine level measurements were performed in duplicates using commercial ELISA kits (BD Pharmingen).
Cytotoxicity assay. Cytotoxicity assay. Cytotoxicity assay. Cytotoxicity assay. This gene was cloned in the retroviral vector pMI-GR1 [12] to obtain the final retroviral vector pTLG ( Figure 1 ). The pTLG expression vector was used as a delivery system to HPC-4 tumor cells. The effectiveness of transduction ranged from 0.1% to 0.5%. Transduced HPC-4 TLG cells following FACS sorting, yielded 1-10% TLG + cells. After propagation of these selected cells and re-sorting, the purity of TLG + cells exceeded 95% (Figure 2) . In parallel, the HPC-4 GFP cells mock-transduced with the original empty pMI-GR1 vector were also more than 95% GFP + (not shown). The amount of TNF secreted from HPC-4 TLG cells was 2,428 ± 466 pg/ml (mean ± SEM), while mock-transduced HPC-4 GFP and parental HPC-4 cells did not produce TNF (Figure 3) . No IL-6, IL-10, MIP1a or RANTES were found in the supernatants of HPC--4 TLG cells (data not shown).
As membrane bound TNF is regarded as important in the cellular interactions [17] , in the next step we analyzed whether synthesized TLG fusion protein was expressed as the membrane-bound form. For this purpose, transduced HPC-4 TLG cells were stained with anti-TNF PE-conjugated mAb. However, taking into consideration significant spillover of green fluorescence from enhanced GFP into PE channel (data not shown), we took an advantage from anti-GFP antibodies conjugated with Alexa Fluor 594, the dye which did not interfere with PE emission spectrum. Anti-GFP antibodies were used in parallel with anti-TNF mAb for cell staining. After staining, the cells were analyzed by flow cytome- We have previously shown that short pre-exposure of monocytes to tumor cells deactivated them, as evidenced by decreased TNF and enhanced IL-10 production [11] . In order to check whether transduced HPC-4 cells act similarly, monocytes were cultured for 4 h with parental HPC-4 or transduced HPC-4 GFP or HPC-4 TLG cells. CD14 + cells were then isolated by FACS sorting and stimulated with HPC-4 cells for 18 h. Figure 7 shows that pre-exposure of monocytes to parental HPC-4 cells inhibited TNF and IL-12 and enhanced IL-10 production. In contrast, HPC-4 TLG cells neither caused inhibition of TNF and IL-12 synthesis nor enhancement of IL-10 production. Pre-exposure of monocytes to mock-transduced HPC-4 GFP cells caused similar production of TNF, IL-10 and IL-12 as those pre-exposed to parental cells.
Cytotoxicity of monocytes pre-exposed to Cytotoxicity of monocytes pre-exposed to Cytotoxicity of monocytes pre-exposed to Cytotoxicity of monocytes pre-exposed to Cytotoxicity of monocytes pre-exposed to g g g g g-irradiated HPC-4 -irradiated HPC-4 -irradiated HPC-4 -irradiated HPC-4 -irradiated HPC-4 TLG TLG TLG TLG TLG Monocytes/macrophages possess significant spontaneous cytotoxicity against tumor cells [16] , which is decreased by the pre-exposure to tumor cells. This decrease is a part of the monocytes' deactivation. To check whether HPC-4 TLG cells may also prevent inhibition of cytotoxicity, monocytes were preincubated with g-irradiated HPC-4 or HPC-4 GFP , or HPC-4 TLG cells, and cytotoxicity against HPC-4 tumor cells was measured. As expected, monocytes pre-exposed to HPC-4 or HPC-4 GFP cells demonstrated lowered cytotoxicity ( Figure 8 ). In contrast, there was no inhibition of cytotoxicity when monocytes were pre-exposed to HPC-4 TLG cells. Figure 7 . Figure 7 . Figure 7 . Figure 7 . Figure 8 . Figure 8 . Figure 8 . For a successful cancer gene therapy, it is fundamental to obtain as many cells transduced with the therapeutic gene as possible. Thus, knowing the actual gene transfer rate is critical. The GFP has made a breakthrough in gene transfer technology. It is a small protein that fits most of the currently used vectors and can be fused with other proteins to yield therapeutic fusion proteins [5, 18, 19] . The use of GFP fusion proteins provides enhanced sensitivity and resolution compared to antibody staining techniques and permits kinetic studies of a fusion protein localization [4, 20] . The construction of the fusion protein often requires the linking of two proteins or protein domains by an appropriate polypeptide linker. Many studies have suggested that the flexibility and hydrophilicity of the linker were very important in preventing the disturbance of the functions of both domains [21, 22] .
In the present study, the TLG fusion gene was constructed by joining the TNF-cDNA and enhanced GFP-cDNA with the LIN23-DNA, coding for a short, flexible and hydrophilic linker Leu Glu [(Gly) 4 Ser] 4 Ala, which allowed retention of GFP and TNF expression. The retroviral vector pTLG carrying the TLG fusion gene was used for transduction of HPC-4 cells. The TLG gene transduced cells exhibited unchanged morphology and proliferation during in vitro culture for more than six months as compared to the parental nontransduced cells. The TLG gene transduced cells secreted a substantial amount of TNF, the presence of which was observed on their mem- (Figures 4 and 5) . In the preliminary set of experiments, we compared membrane and intracellular expression of TNF in HPC-4 TLG cells without anti-GFP staining. Under such conditions, the amount of double positive cells was only around 50-60% of GFP + cells (for both membrane and intracellular staining -data not shown). Such a relatively small amount of double positive cells could be a result of a spillover of green fluorescence from enhanced GFP to the PE channel, which could not be fully compensated during FACS analysis. To resolve this issue, we changed our detection method and introduced staining with anti-GFP Ab conjugated with Alexa Fluor 594, a dye which does not interfere with PE. This approach, however, did not improve the expression ratio, neither in surface nor intracellular staining. Thus, the relatively low number of double positive HPC-4 TLG cells during membrane staining was probably due to secretion of TNF, cleaved rapidly from the TLG protein, to the medium. In the case of intracellular staining, the high amount of TLG present in the cytoplasm is probably neither properly folded nor fully accessible for both antibodies used for FACS analysis. Such an explanation is supported by Western blot analysis of HPC--4 TLG cell lysates showing intracellular expression of the fusion protein ( Figure 5B ). It shows that there is also a band of free GFP present, which was probably left after the cleavage of TNF from TLG and its secretion. However, the exact trafficking and processing of the TLG fusion protein in transduced HPC-4 cancer cells has not been investigated in the present paper, and should be addressed in our future studies.
It has been previously shown that monocytes respond to tumor, but not normal, cells by producing several toxic mediators: TNF, ROI, radical nitrogen intermediates (RNI) and increased cytotoxicity [16, 23, 24] . On the other hand, clinicopathological evidence suggests that TIM, of which monocytes are precursors, may enhance the growth of some tumors [25] . Our previous data showed that although the first contact of monocytes with tumor cells induces antitumor activity, secondary contact leads to their deactivation (diminished TNF, IL-12 and ROI production, decreased cytotoxicity and enhanced IL-10 production), i.e. they became M2 polarized monocytes [25] .
In the present experiments, we have investigated how the contact with tumor cells expressing TNF changes the activity of monocytes. In comparison to parental cells, HPC-4 TLG cells induced higher production of TNF by monocytes and lower IL-10. Contrary to what could be expected, we found that HPC-4 GFP cells, compared to parental HPC-4 cells, caused a decrease in the secretion of all tested cytokines by monocytes. Although we have no formal proof, this phenomenon may be due to more accelerated apoptosis of GFP transduced cells [26] , which are rapidly phagocytosed by monocytes during their co-culture. Phagocytosis of apoptotic cells by monocytes, as evidenced by us and others, does not lead to secretion of TNF, IL-10 or IL-12. The only cytokine released by monocytes/macrophages during phagocytosis of apoptotic cells is TGFb, which was not analyzed in our study. Another concern may arise when analyzing TNF secretion in the co-culture of monocytes and HPC-4 TLG cells. In this case, the question is whether the TNF release comes from the transduced cells (GFP-TNF), or from the monocytes alone. Indeed, in this situation both cell populations may be a source of TNF; however, as indicated in the legend of Figure 6 , the amount of TNF secreted by HPC-4 TLG cells (900 ± 180 pg/ml of TNF/3 × 10 4 cells/ml) is far less compared to the level secreted by monocytes, thus having little effect on the total level of this cytokine in the co-culture supernatants.
The CD14 + monocytes sorted out from the co-culture with HPC-4 cells and restimulated with HPC-4, showed decreased TNF and IL-12 production. However, CD14 + cells isolated from the co-culture with HPC-4 TLG produced a higher level of TNF and IL-12 and a diminished level of IL-10. This may suggest that, in the presence of TNF on the cell surface of HPC--4 TLG or released by them, no deactivation of monocytes occurred. The observation that cytotoxic activity of monocytes pre-exposed to HPC-4 TLG cells was not diminished also confirmed this suggestion.
The ability of TNF to activate monocytes/macrophages has been widely reported [17, 27, 28] . Activated monocytes/macrophages produce several toxic mediators such as RNI, ROI and TNF, which are probably directly involved in tumor cell killing in vitro. TNF may be also involved in indirect tumor cell killing by inducing RNI and ROI [29] . The inhibition of tumor growth after transduction of cancer cells with DNA construct coding for TNF has been observed, although different experimental models and divergent results concerning the activity of membrane-bound vs. secreted TNF have been reported [6, 17, 30] . It has been suggested that in immunocompetent mice, tumor regression was T cell-dependent [6, 30] , while in immunodeficient mice the effect was macrophage--dependent [6] . Membrane bound TNF is regarded as important in the cellular interactions, e.g. with murine macrophages [17] . In keeping with this, HPC-4 TLG cells effectively stimulated human monocytes for TNF release, while decreasing IL-10 and IL-12 secretion.
In summary, the present data indicates that human cancer cells transduced with TNF-cDNA release TNF and express its membrane-bound form. These
